CIK 0001517022
- Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 208756903
- Phone
- +1 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- 4 Grant or award SVP, CFO, CBO & Treasurer acquired 194,900 shares (grant or award)
- 4 Exercise or conversion Director acquired 20,100 shares (option exercise)
- 4 Grant or award SVP, CFO, CBO & Treasurer acquired 350,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Planned sale SVP, Chief Legal Officer sold 12,016 shares at $1.26 ($15,140)
- 4 Planned sale SVP, Chief Operating Officer sold 34,840 shares at $1.26 ($43,898)
- 4 Open-market sale SVP, Chief Medical Officer sold 27,000 shares at $1.15 ($31,050)
- 4 Open-market sale SVP, Chief Operating Officer sold 8,661 shares at $1.58 ($13,684)
- 4 Open-market sale SVP, Chief Legal Officer sold 5,974 shares at $1.58 ($9,439)
- 4 Open-market sale CEO and President sold 46,570 shares at $1.58 ($73,581)
- 4 Open-market sale SVP, Chief Medical Officer sold 7,169 shares at $1.58 ($11,327)
- 4 Planned sale SVP, Chief Legal Officer sold 7,411 shares at $1.52 ($11,265)
- 4 Open-market sale SVP, Chief Operating Officer sold 10,744 shares at $1.52 ($16,331)
Page 3 of 19 · 378 filings